FDA Ends Suspension of Chikungunya Vaccine, Adjusts Label

Regulators in May effectively stopped administration of the vaccine.

A box of Ixchiq chikungunya vaccine at a pharmacy in Le Reunion, in this file photograph. Richard Bouhet/AFP via Getty Images

The Food and Drug Administration has lifted its hold on a vaccine against chikungunya, the agency announced on Aug. 6, as it adjusted the label for the shot.

The FDA is ending its recommended pause, which effectively stopped administration of Valneva’s vaccine Ixchiq, the agency said in a statement.